Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 13, 2025 07:00 ET | Source: Microbix Biosystems Inc.

Microbix & Aurevia Introduce Novel EQA Scheme

MISSISSAUGA, Ontario and HELSINKI, Finland, May 13, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, and...
July 15, 2024 13:00 ET | Source: DelveInsight Business Research LLP

Bacterial Vaginosis Market to Register Incremental Growth During the Study Period (2020–2034) | DelveInsight

New York, USA, July 15, 2024 (GLOBE NEWSWIRE) -- Bacterial Vaginosis Market to Register Incremental Growth During the Study Period (2020–2034) | DelveInsight The current therapeutic landscape of...
August 08, 2023 08:15 ET | Source: Transparency Market Research

Vaginitis Diagnostics Market to reach USD 4.1 billion in 2031, expanding at a CAGR of 9.5%: TMR Report

Wilmington, Delaware, United States, Aug. 08, 2023 (GLOBE NEWSWIRE) -- The global vaginitis diagnostics market is projected to flourish at a CAGR of 9.5% from 2022 to 2031. As per the report...
October 23, 2019 07:30 ET | Source: Harrow Health, Inc.

Solas BioVentures Co-Founder David Adair, M.D. Joins Mayfield Pharmaceuticals Board of Directors

BOSTON, Oct. 23, 2019 (GLOBE NEWSWIRE) -- Mayfield Pharmaceuticals, the women’s health-focused subsidiary of Harrow Health, Inc. (NASDAQ: HROW), today announced David Adair, M.D. will join the...
October 08, 2019 07:35 ET | Source: Harrow Health, Inc.

Mayfield Pharmaceuticals to Present at the SVB Leerink New Treatments Focused on Women’s Health Conference on October 10, 2019

BOSTON, Oct. 08, 2019 (GLOBE NEWSWIRE) -- Mayfield Pharmaceuticals, the women’s health-focused subsidiary of Harrow Health, Inc. (NASDAQ: HROW), today announced its Chief Executive Officer, Melissa...
July 31, 2019 07:30 ET | Source: Harrow Health, Inc.

Harrow Health Announces Launch of Mayfield Pharmaceuticals

NASHVILLE, Tenn., July 31, 2019 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW), today announced it has filed a Form 8-K with the Securities and Exchange Commission containing a corporate...
January 18, 2018 07:00 ET | Source: Melinta Therapeutics

Melinta Therapeutics Announces Initiation of Program for Radezolid in Patients with Bacterial Vaginosis

NEW HAVEN, Conn., Jan. 18, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ:MLNT), a commercial-stage company developing and commercializing novel antibiotics to treat serious bacterial...